Introduction 32
Understanding the mechanisms by which cis-regulatory elements, or enhancers, activate transcription has 33 been intensively studied for the last three decades, yet our knowledge remains incomplete (Shlyueva et al. 34 2014) . As shown by ChIP-seq experiments, transcription factors may bind to thousands of putative 35 enhancer regions in the genome (Moorman et al. 2006; Li et al. 2008 ), yet a large fraction of them are 36 likely inactive. For example, transcription factors may bind to enhancers that have been primed by 37 pioneer transcription factors but are not yet active (Zaret and Carroll 2011; Spitz and Furlong 2012) or 38 they may be sequence-specific repressors that actively repress the enhancers to which they are bound 39 . This not only questions the strict temporal model in which the poised enhancer state precedes 62 enhancer activation, but also suggests a role for poised enhancers in tissue patterning. 63 A widespread role for poised enhancers in tissue patterning is consistent with large-scale DNase 64 hypersensitivity (DHS) assays across a variety of cell types representing stages of human development 65 (Stergachis et al. 2013 ). These data also show that enhancers are frequently accessible across broadly 66 related cell types and only become active in specific lineages, raising the possibility that poised enhancers 67 in embryonic tissues are predisposed for activation spatially, and that enhancer activation is regulated by 68 signals that control pattern formation. 69
During tissue patterning, developmental signals (or morphogens) are often generated at and propagated 70 from precise locations within the embryo, typically leading to the graded activation of signal transduction 71 pathways and transcription factors across fields of cells (Briscoe and Small 2015) . Depending on the 72 strength of signaling, different target genes are activated, giving rise to distinct cell fates across the 73 gradient. Activation of already accessible enhancers is a logical mechanism by which signal transduction 74 pathways could mediate precise cellular responses to morphogens. The broad distribution of poised 75 enhancers may ensure that a sufficient number of cells can respond to specific developmental signals in 76 the appropriate manner, thus facilitating pattern formation. 77
While a function of poised enhancers in pattern formation is plausible, in many systems the hypothesis is 78 difficult to test due to the scarcity and heterogeneity of embryonic tissues. To analyze a possible role for 79 poised enhancers during pattern formation in the embryo, we used the tractable Drosophila dorso-ventral 80 (DV) patterning as model system. In the Drosophila embryo, DV patterning begins with localized 81 activation of the Toll (Tl) receptor by maternal components, which leads to the formation of a Dorsal (Dl) 82 morphogen gradient and gives rise to at least three cell fates with distinct gene expression programs along 83 the DV axis: mesoderm on the ventral side, neurectoderm in the lateral regions and dorsal ectoderm on 84 the dorsal side (Hong et al. 2008) (Fig. 1a ). For simplicity, we focused on the cell fates at the ends of the 85 gradient, mesoderm and dorsal ectoderm. 86
The advantage of the Drosophila DV system is that large amounts of cells can be obtained from these two 87 tissues without the need for cell sorting or tissue dissection. This is made possible by the availability of 88 maternal mutants where all embryos in the progeny consist entirely of either mesodermal or dorsal 89 ectodermal precursor cells (Schneider et al. 1991) . In Tl 10b mutant embryos, Dl activity is uniformly high 90 (but not above wild-type levels) leading to mesodermal precursor fate. In gd 7 mutant embryos, Dl is not 91 activated, resulting in uniformly high signaling activity of the fly BMP2/4 ortholog Decapentaplegic 92 (Dpp) (but below wild-type maximum levels, see Ashe and Levine 1999) and the specification of dorsal 93 ectodermal fate in the entire embryo. These mutants have frequently been used in the past because they 94 allow the analysis of patterning across the Dl activity gradient (e.g. Stathopoulos Three cis-regulatory sequences, those regulating dpp, zerknüllt (zen), and tolloid (tld), have been shown to 108 be ventrally repressed by Dl, allowing spatially-restricted activation of these genes on the dorsal side of 109 the embryo (Irish and Gelbart 1987; Rushlow et al. 1987; Ip et al. 1991; Huang et al. 1993; Kirov et al. 110 1994; Ratnaparkhi et al. 2006) . 111
Using the DV patterning system, we analyzed the state of enhancers during patterning across tissues. We 112
show that DV enhancers are indeed in a poised state in the tissue where they are not induced, including at 113 the three loci that are known to be repressed. These enhancers are accessible to transcription factors, 114 albeit at lower levels than in their active state, and marked by significant levels of H3K4me1 but low 115 levels of H3K27ac. Their H3K27me3 levels were more variable. We find no evidence that these poised 116 124 To characterize the enhancer states during DV patterning, we first assembled a list of known DV 125 enhancers that have been verified by transgenic lacZ reporter assays (see Supplemental Table S1 ). We 126 identified 37 enhancers that exhibit activity in the mesoderm but remain uninduced in the dorsal 127 ectoderm, and 22 enhancers that drive expression in the dorsal ectoderm but remain uninduced in the 128 mesoderm ( Fig had the highest levels of Dl and Twi, the "closed" control set had the lowest levels, and uninduced 151 enhancers had statistically distinct intermediate levels ( Fig. 1B left) . 152 Dorsal ectodermal fate is induced by Dpp signaling, which activates the transcription factors Mothers 153 against dpp (Mad) and Zen (Rusch and Levine 1997; Lin et al. 2006) . We therefore analyzed the 154 occupancy of Mad and Zen in gd 7 embryos and found that their occupancy at both active DEEs and 155 uninduced MEs was also significantly higher than at the "closed" control enhancers ( Fig. 1B, middle) . 156
Results

123
Uninduced DV enhancers are accessible to transcription factors albeit at lower levels
Again, their occupancy at uninduced enhancers was significantly lower than at active enhancers ( Fig. 1B,  157 middle), further supporting the hypothesis that uninduced enhancers are bound by transcription factors, 158 but to a lesser extent than active enhancers. 159
The observation that uninduced DV enhancers are bound by transcription factors suggests that these 160 enhancers have been primed by a pioneer transcription factor. A potential pioneer transcription factor is 161 Zelda (Zld, encoded by the zld gene also known as vfl), which is present ubiquitously in the Drosophila We therefore analyzed the occupancy of Zld at active, uninduced and closed enhancers. Since Zld is 167 present in both tissues, we merged the results for all active and all uninduced enhancers from both tissues 168 ( Fig. 1B right) . We found that uninduced enhancers remain highly bound by Zld albeit at slightly lower 169 levels than at active enhancers. The closed regions that we used as controls were not bound by Zld or 170 bound at very low levels. This suggests that Zld specifically primes early enhancers and that it primes 171 them in the entire embryo, whether or not the enhancers are induced. as expected. In Tl 10b mutants, where these enhancers are repressed, they are occupied by Zld, Dl and Twi. 193 This is consistent with Zld's role as pioneer factor and Dl's role as repressor at these enhancers. However, 194 these and other DEEs such as tup are also occupied by Twi to some degree, although Twi is an activator 195 and has no known role in regulating these enhancers. This suggests that the DEEs are to some degree 196 accessible to transcription factors in the tissue in which they are not induced, presumably due to the 197 pioneering activity of Zld. 198 A similar pattern was observed for MEs. In Tl 10b mutants, the sna enhancer is highly occupied by Dl and 199 Twi, which are required for activation (Ip et al. 1992 ). However, even in the dorsal ectodermal tissue of 200 gd 7 mutants, in which sna is not expressed, the enhancer is occupied by Zld, as well as Mad and Zen. 201
Consistent with Zld being critical for enhancer access, in the rare case where Zld does not occupy an 202 uninduced enhancer, other transcription factors are also not bound (see Mef2 in Fig. 1C ). 203
Taken together, these results suggest that uninduced enhancers are frequently primed and bound by 204 transcription factors, albeit to a lower degree than in the active state. This level of accessibility might 205 allow these enhancers to be inactive but responsive to changes in signaling and transcription factor 206 activity. 207
Uninduced enhancers are marked by H3K4me1 and low H3K27ac and thus carry a
208 poised enhancer signature 209 Having identified three distinct enhancer states, we next investigated their histone modification status. We 210 performed ChIP-seq experiments with antibodies against H3K27ac and H3K4me1 in both mutant 211 embryos and calculated the enrichment (± 500 bp from enhancer center) at active and uninduced 212 enhancers (again each from both mutants), as well as "closed" enhancers as a control. 213
Uninduced enhancers had overall significantly higher levels of H3K27ac as compared to closed control 214 regions ( Fig. 2A , p < 10 -6 , Wilcoxon rank sum test) but their levels were significantly lower than at active 215 enhancers ( Fig. 2A , p < 10 -6 , Wilcoxon rank sum test). Indeed, when we plotted the relative difference for 216 each enhancer between the two tissues, the difference in H3K27ac levels between active and uninduced 217 enhancers became more significant (p < 10 -9 ) (Fig. 2B ). This suggests that uninduced enhancers have low 218 levels of H3K27ac, and that the levels significantly increase when the enhancers are active. 219 When we analyzed H3K4me1 levels, we found that uninduced enhancers also have H3K4me1 238 significantly above the levels of the control ( Fig. 2A , p < 10 -13 , Wilcoxon rank sum test), consistent with a 239 poised enhancer signature. However, H3K4me1 enrichments were slightly lower in the uninduced state 240 than in the active state ( Fig. 2A , p < 10 -3 , Wilcoxon rank sum test). This small but consistent difference 241 became more significant when analyzing the relative difference in H3K4me1 at enhancers (p < 10 -5 ) (Fig.  242   2B ). Furthermore, close examination of the profiles of H3K4me1 at individual enhancers confirms this 243 trend (see Fig. 2C ). However, the difference is small relative to the difference between closed and 244 uninduced regions, consistent with H3K4me1 being a marker for both poised and active enhancers. 245
Finally, we specifically examined whether the known enhancers repressed by Dl (zen, dpp and tld in Fig.  246 2C) had a characteristic histone modification signature distinct from other uninduced enhancers. The 247 histone signature of H3K4me1 and low H3K27ac at repressed enhancers was indistinguishable (see other 248 examples in Fig. 2C ). Thus, the poised enhancer signature is also characteristic for enhancers regulated by 249 transcriptional repressors. Whether there is a histone modification that is specifically associated with 250 transcriptional repressors is not known. H3K27me3 is a well-studied repressive mark but it is deposited 251 by Polycomb group proteins, which are not known to associate with sequence-specific transcriptional 252
repressors (Simon and Kingston 2013) . 253 When we analyzed H3K27me3 ChIP-seq data in Tl 10b and gd 7 embryos, we found that H3K27me3 is 262 present at DV enhancers, but at remarkably variable levels. Some enhancers had very high levels of 263 H3K27me3, while more than half of them had no enrichment above background (Fig. 3A) . Despite the 264 variance, however, there was a significant trend for enhancers to have higher H3K27me3 levels in the 265 uninduced versus active state (Fig. 3B , p < 10 -2 ), consistent with previous findings (Bonn et al. 2012) . including GAGA factor (Trithorax-like or Trl) (Strutt et al. 1997 ). We therefore identified high-299
H3K27me3 is not a good marker for uninduced enhancers or sequence-specific
confidence PREs through the co-occupancy of GAGA factor, which is not specific for PREs but gives 300 high signal in ChIP experiments, and Polycomb (Pc) itself, which is indirectly bound to DNA but which 301 is highly specific for PREs (Schuettengruber et al. 2009; Schuettengruber et al. 2014) . 302
If the levels of H3K27me3 at enhancers depend on nearby PREs, we expect that DV enhancers with high 303 H3K27me3 levels will be located closer to PREs than those without. Indeed, DV enhancers with 304
H3K27me3 levels above 2-fold enrichment have PREs that are relatively close (median distance is less 305 than 10 kb), while DV enhancers without H3K27me3 enrichment have PREs that are much further away 306 (median distance is ~200 kb (Fig. 3D , p < 10 -5 , Wilcoxon rank sum test). The correlation between PREs 307 and H3K27me3 can also be observed at individual DV enhancer regions, where the levels of H3K27me3 308 often peak close to PREs (Fig. 3C ). Finally, the correlation between PREs and H3K27me3 is not specific 309 for DV enhancers since the same trend was observed for all Zld-bound regions, which include most early 310 enhancers (Fig. 3D) . These results strongly support the traditional model that high levels of H3K27me3 311 depend on nearby PREs. 312
The anti-correlation between gene activation and H3K27me3 suggests that active enhancers can reduce 313 the H3K27me3 levels deposited by nearby PREs. To consider alternative models, we also probed the 314 possibility that repressors at enhancers might directly promote H3K27me3 deposition. However, the 315 known Dl-repressed enhancers did not stand out in their H3K27me3 profile as compared to other 316 uninduced enhancers (Fig. 3C) . For example, the Dl-repressed dpp enhancer has very high levels of 317 H3K27me3 in the repressed state, while another Dl-repressed enhancer, that of tld, has much lower levels. 318 Furthermore, high levels are also observed at enhancers that are not repressed by Dl, including tup. Thus, 319 while the levels of H3K27me3 correlate with the presence of PREs, they do not correlate with Dl-320 dependent repression. While we cannot rule out a subtle role for repressors in modulating H3K27me3 321 levels, our data suggest that the strongest determinants of H3K27me3 levels are nearby PREs and lack of 322 gene activation. Therefore, H3K27me3 cannot be considered a specific marker for uninduced or repressed 323
enhancers. 324
Poised DV enhancers are specifically generated during tissue patterning and are not 325 poised for future activation 326 Our results so far suggest that uninduced enhancers have a histone signature that is indistinguishable from 327 the poised enhancer signature described in mammals, with or without H3K27me3. This raises the 328 question whether the Drosophila DV enhancers are at some point poised for future activation. 329
We first considered the possibility that DV enhancers are poised prior to activation, when the enhancers 330 are primed by Zld before Dl-dependent transcription begins. Based on a careful time-course analysis (Li 331 et al. 2014 ), however, the primed DV enhancers do not show the poised signature since they gradually 332 accumulate H3K27ac but are not yet marked with H3K4me1 or H3K27me3 before DV patterning takes 333 place (Fig. 4A ). This suggests that the DV enhancers do not have any poised enhancer signature when 334 they are primed prior to activation. 335 To nevertheless test the possibility, we analyzed DNase I hypersensitivity (DHS) data across 350 embryogenesis (Thomas et al. 2011) . We found that DV enhancers are most accessible during DV 351 patterning (stages 5 and 9), when they are active, and become less accessible at subsequent stages (Fig.  352   4B ). This argues against additional roles of these enhancers past DV patterning. 353
Taken together, our analysis suggests that the poised enhancer signature is specifically generated during 354 DV patterning at uninduced enhancers. There is no evidence that it precedes enhancer activation, arguing 355 that it marks spatial rather than temporal regulation in our system. 356
Discussion
357
The poised enhancer signature as a marker for spatial enhancer regulation 358 We found that DV enhancers acquire the poised enhancer signature (low H3K27ac, some H3K4me1) 359 specifically during tissue patterning (model in Fig. 5 ). Before DV patterning, these enhancers are primed 360 by the pioneer transcription factor Zld and have a very different enhancer signature (some H3K27ac but 361 no H3K4me1). It is unclear whether this enhancer signature is typical for primed enhancers since the 362 priming occurs during the maternal-to-zygotic transition. Nevertheless, it clearly shows that the poised 363 enhancer signature does not precede enhancer activation in the DV system and thus is specifically 364 generated in the tissue in which the enhancers are not activated. During subsequent stages, the DV 365 enhancers close again, perhaps because key transcription factors such as Zld are no longer present 366 (Kanodia et al. 2012) . It is also possible that repressive chromatin modifying complexes help to 367 decommission enhancers to reduce their activity in subsequent developmental programs (Whyte et al. 368 2012) . 369
This suggests that the poised enhancer signature should not be interpreted as "poised for future 370 activation" but rather represents a "poised state", one that would lead to activation in the presence of the 371 right developmental signals. Since the "poised enhancer" is accessible to transcription factors, it can read 372 out the activity of appropriate signal transduction pathways and respond to them. Therefore, enhancers 373 may be in a poised state for some time during development to remain signal-responsive and allow cells to 374 adjust to changes in signals from surrounding cells during pattern formation. However, in the absence of 375 appropriate signals, a poised enhancer may not become active and instead may proceed directly to a 376 closed state. 377 388 We found that the three DV enhancers that are actively repressed by Dl have the poised enhancer 389 signature. This raises the possibility that sequence-specific repressors actively help generate the poised 390 enhancer signature and prevent these enhancers from becoming active. 391
A role for repressors in keeping poised enhancers inactive
In support of this hypothesis, the poised enhancer signature fits strikingly well with previous mechanistic Another reason is that the pattern by which poised enhancers occur during lineage development is 418 consistent with the expected widespread use of repressors in signaling and tissue patterning. In addition to 419 sequence-specific repressors employed during tissue patterning, most developmental signal transduction 420 pathways have their own dedicated mechanism to repress target genes in the absence of signaling activity 421 (Barolo and Posakony 2002; Affolter et al. 2008 ). The fact that these signal transduction pathways are 422 highly conserved across evolution supports the notion that repression is an integral part of enhancer 423 regulation. 424 425 Finally, the involvement of repressors in keeping poised enhancers inactive has important mechanistic 426 implications and predictions that have not been discussed to our knowledge. An active battle between 427 activators and repressors in controlling histone acetylation at the poised state implies a monocycle 428 between opposing enzymes, thus acetylation by acetyl transferases and deacetylation by deacetylases. 429
Mechanistic implications for poised enhancers with repressors
Analogous to phosphorylation-dephosphorylation dynamics found at some enzymes, such monocycles 430 can create switch-like behaviors and were therefore termed zero-order ultrasensitivity (Goldbeter and 431 Koshland 1981; Ferrell and Ha 2014) . In other words, repressors could make enhancers ultrasensitive in 432 their response to activation signals. 433
Such zero-order ultrasensitivity predicts that a repressed enhancer can be very sensitive to activation, so 434 that only a small amount of activation signal can lead to significant induction (Melen et al. 2005; Ferrell 435 and Ha 2014). This is particularly important in the response to morphogen gradients, where a certain 436 threshold concentration leads to enhancer activation and expression of downstream target genes. At the 437 same time, zero-order ultrasensitivity also implies that a strongly repressed state is relatively stable 438 against inappropriate activation. For example, the role of Polycomb repression, found at important 439 developmental genes, could be to keep enhancers in the repressed regime until they are activated. 440
In summary, a model in which poised enhancers are actively balanced between activators and repressors 441 could provide a mechanism to explain the ultrasensitive response of enhancers to patterning signals. This 442 could explain the widespread occurrence of a distinct poised enhancer state during tissue patterning. Since 443 the model makes clear mechanistic predictions, it opens new avenues for further exploration and tests in 444 the future. 445 447 The fly stock Tl 10b is from Bloomington (Tl 10b , Bloomington stock center, Bloomington, #30914). The gd 7 448 stock was a kind gift from Mike Levine. gd 7 /gd 7 females gd 7 /Y males and were obtained from the 449 gd 7 /winscy, hs-hid stock by heat shocking 1 day-old larvae for 1 h at 37°C, followed by a second heat 450 shock 24 h later. T(1;3)OR60/ Tl 10b , e 1 females and Tl 10b /TM3, e 1 , Sb 1 , Ser 1 males were selected from the 451 stock consisting of genotypes Tl 10b /TM3, e 1 , Sb 1 , Ser 1 and T(1;3)OR60/ TM3, e 1 , Sb 1 , Ser 1 . Wild-type 452 embryos (Oregon-R) at 2-4 h AED were used for GAGA, and Pc ChIP-seq. Embryos were collected on 453 apple juice plates for 2 h at 25°C from cages and then matured at 25°C for another 2 h (2-4 h after egg 454 deposition (AED)). Embryos were crosslinked for 15 min with 1.8% formaldehyde (final concentration in 455 water phase). 456 Zld, H3K27ac, H3K4me1, and H3K27me3; wild type embryos for GAGA and Pc; and gd 7 embryos for 465 Mad, Zen, Zld, H3K27ac, H3K4me1, and H3K27me3. 466
Methods
446
Stock maintenance and embryo collection
ChIP-seq experiments
Library preparation
467 Different combinations of library preparation kits and barcodes were used for ChIP-seq and mRNA-seq 468 library preparations (see Supplemental Table S3 ) and libraries were prepared according to manufacturer's 469 instructions. ChIP-seq libraries were prepared from 5-15 ng ChIP DNA or 100 ng WCE input DNA and 470 sequenced on the GAIIX (Illumina) or the HiSeq 2500 (Illumina). 471
ChIP-seq data processing 472
Sequenced ChIP-seq reads were aligned to UCSC Drosophila melanogaster reference genome dm3 using 473 Bowtie v1.1.1 (Langmead et al. 2009 ), allowing up to two mismatches and retaining only uniquely 474 aligning reads. Aligned reads were extended to the sample's estimated fragment size using the chipseq 475
Bioconductor library (Huber et al. 2015) . 476
Replicates of genotype-specific WCE input samples for Tl 10b and gd 7 were merged, and these merged 477
WCEs were used for enrichment calculations and peak calling. 478
Transcription factor enrichments within each enhancer were calculated within a 201 bp window centered 479 at the transcription factor's ChIP-seq signal summit. Enrichment calculations were normalized for both 480 differences in read count and estimated fragment size between ChIP and WCE samples. Histone 481 modification enrichments were calculated similarly, but using a 1001 bp window centered on the 482 enhancer region. The replicates for each transcription factor and histone modification with the highest 483 median enrichment were used for further analysis. 484 485 Fold-change in ChIP-seq enrichments of H3K27ac, H3K4me1 and H3K27me3 between Tl 10b and gd 7 486 were normalized to account for differences in ChIP efficiency. The normalization factor for each histone 487 modification was determined by the median fold-change in ChIP-seq enrichment at MACS2 peaks that 488 were detected in both mutant embryos. 489 mRNA in situ hybridization data from the BDGP database were used for this purpose. For some of these 509 enhancers, no target gene was identified with confidence and thus those enhancers were not included in 510 mRNA-seq analysis shown in Supplemental Fig. S1 (see Supplemental material for more information). 511
Normalization of histone modification ChIP-seq data
mRNA-seq experiments
Active enhancers, uninduced enhancers and closed regions 512
Active enhancers are MEs in the mutant Tl 10b and DEEs in gd 7 embryos. Uninduced enhancers are MEs in 513 gd 7 embryos and DEEs in Tl 10b embryos. A total of 100 "closed regions" were randomly selected from 514 published DHS regions (Thomas et al. 2011) , which were only active at stage 14 and not in any of the 515 earlier stages. The "closed regions" were also required to overlap with peaks from published H3K27ac 516 14-16 AED h in wild type embryos (modENCODE ID:4120) (Contrino et al. 2012) . DHS regions that 517 overlapped with a TSS (2 kb centered on a TSS) were excluded from the selection. 518
ChIP-seq binding profiles at single genes 519
Single gene profiles of histone modifications show ChIP-seq enrichment values over input calculated 520 using a 501 bp sliding window. Transcription factor profiles are shown in reads per million. 521
Distance to putative PREs 522
Putative PREs were defined as regions that result from overlapping Pc and GAGA peaks (min 50 bp 523 overlap) from ChIP-seq in wild-type 2-4 h AED embryos. Overlapping regions were combined to one 524 putative PRE region. For Zld-bound regions, peaks were called by MACS2 on the wild-type Zld ChIP-seq 525 sample and filtered for those with Zld binding of at least 2-fold over background in either gd7 or Tl 10b . 526
Enrichment of H3K27me3 was calculated for each Zld peak in a region 1,000 bp centered at the peak 527 summit. Both known enhancers and Zld regions were divided into H3K27me3 "low" and "high" groups 528 based on an enrichment threshold of two-fold below or above input, respectively. Coordinates for putative 529 PREs can be found in Supplemental Table S2 and distances of known DV enhancers to the closest 530 putative PRE can be found in Supplemental Table S1 . 
